Abstract: Novel dry powder compositions comprising and methods relating thereto are provided. The dry powder compositions comprise PDE5 inhibitors, such as vardenafil, or pharmaceutically acceptable salts or esters thereof. The dry powder compositions may optionally include an carrier/excipient. The concentration of active agent may be at least about 2% by weight. Methods of aerosolizing the dry powder compositions and using them to treat various diseases are also disclosed.

Abstract: Novel dry powder compositions comprising and methods relating thereto are provided. The dry powder compositions comprise PDE5 inhibitors, such as vardenafil, or pharmaceutically acceptable salts or esters thereof. The dry powder compositions may optionally include an carrier/excipient. The concentration of active agent may be at least about 2% by weight. Methods of aerosolizing the dry powder compositions and using them to treat various diseases are also disclosed.

Abstract: A display assembly (FIG. 1) comprises a plurality of panels (1) joined together by elongate connecting members (2, 3). Each panel has a removable frame formed by extrusions (6) in each of which is a slot (13) having a restricted entrance (FIG. 2). Each connecting member (2, 3) has two heads (18) which can be slid into slots (13) in adjacent panels (1), from one end, to join the panels together, each head being too wide to pass through the restricted entrance of the slot. A central body portion (20) of the connecting member, to which the heads (18) are joined, is positioned between, and extends outwards between, adjacent panels to facilitate access to the connecting member and enable the screen assembly to be dismantled easily. A longitudinal slot (50), (FIGS. 21 to 23), can be provided in a part of the body (20) that is accessible between connected panels, to enable components such as shelf-supporting brackets to be secured to the screen assembly.